Back to funds
View filing
a16z Capital Management, L.L.C.
Updated 6 days agoManaged by A16Z Capital Management, L.L.C. • Latest filing Q3 2026
Portfolio value
$19.9B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $1.6B |
| Q1 2026 | $1.3B |
| Q2 2026 | $14.2B |
| Q3 2026 | $19.9B |
Top holdings
24 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $18.4B | 121.78M | 92.35% | — | |
| 2 | $592.3M | 28.22M | 2.98% | — | |
| 3 | ? N/A BRAVEHEART BIO INC | $206.7M | 10.23M | 1.04% | — |
| 4 | $160.7M | 782.9K | 0.81% | — | |
| 5 | $87.8M | 5.57M | 0.44% | — | |
| 6 | $80.3M | 2.85M | 0.40% | — | |
| 7 | $74.8M | 1.02M | 0.38% | — | |
| 8 | ? N/A SCRIBE THERAPEUTICS INC | $56.7M | 3.08M | 0.29% | — |
| 9 | $53.9M | 2.57M | 0.27% | — | |
| 10 | $46.3M | 1.70M | 0.23% | — | |
| 11 | ? N/A STANDARD NUCLEAR INC | $34.5M | 2.92M | 0.17% | — |
| 12 | ? N/A DAMORA THERAPEUTICS INC | $26.3M | 1.24M | 0.13% | — |
| 13 | $22.9M | 3.23M | 0.12% | — | |
| 14 | $21M | 1.43M | 0.11% | — | |
| 15 | $15.2M | 21.0K | 0.08% | — | |
| 16 | $11.6M | 274.6K | 0.06% | — | |
| 17 | $8.6M | 2.13M | 0.04% | — | |
| 18 | $8.1M | 415.0K | 0.04% | — | |
| 19 | ? N/A BITGO HOLDINGS INC | $4.9M | 666.4K | 0.02% | — |
| 20 | ? N/A NAUTILUS BIOTECHNOLOGY INC | $3.8M | 2.66M | 0.02% | — |